The Journal of Contemporary Dental Practice

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 20 , ISSUE 9 ( September, 2019 ) > List of Articles

EDITORIAL

Pyroptosis and Oral Cancer

Piyush Jain

Citation Information : Jain P. Pyroptosis and Oral Cancer. J Contemp Dent Pract 2019; 20 (9):1001-1002.

DOI: 10.5005/jp-journals-10024-2682

License: CC BY-NC 4.0

Published Online: 01-09-2019

Copyright Statement:  Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Man SM, Karki R, et al. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev 2017;277(1):61–75. DOI: 10.1111/imr.12534.
  2. Miao EA, Rajan JV, et al. Caspase-1-induced pyroptotic cell death. Immunol Rev 2011;243(1):206–214. DOI: 10.1111/j.1600-065X.2011.01044.x.
  3. Cookson BT, Brennan MA. Pro-inflammatory programmed cell death. Trends Microbiol 2001;9:113–114. DOI: 10.1016/S0966-842X(00)01936-3.
  4. Xia X, Wang X, et al. The role of pyroptosis in cancer: pro-cancer or pro-“host”? Cell Death Dis 2019;10(9):1–3. DOI: 10.1038/s41419-019-1883-8.
  5. Wu CS, Chang KP, et al. ASC contributes to metastasis of oral cavity squamous cell carcinoma. Oncotarget 2016;7(31):50074–50085. DOI: 10.18632/oncotarget.10317.
  6. Wei Q, Mu K, et al. Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression. Lab Invest 2014;94:52–62. DOI: 10.1038/labinvest.2013.126.
  7. Yue E, Tuguzbaeva G, et al. Anthocyanin is involved in the activation of pyroptosis in oral squamous cell carcinoma. Phytomedicine 2019;56:286–294. DOI: 10.1016/j.phymed.2018.09.223.
  8. Iriti M, Varoni EM. Chemopreventive Potential of Flavonoids in Oral Squamous Cell Carcinoma in Human Studies. Nutrients 2013;5(7):2564–2576. DOI: 10.3390/nu5072564.
  9. Sarode G, Sarode SC, et al. Is oral squamous cell carcinoma unique in terms of intra-and inter-tumoral heterogeneity? Trans Res Oral Oncol 2017;2:11–16. DOI 10.1177/2057178X17703578.
  10. Nilendu P, Sarode SC, et al. Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistance. Cell Oncol (Dordr) 2018;41(4):353–367. DOI: 10.1007/s13402-018-0388-2.
  11. Sarode SC, Sarode GS, et al. A new classification for potentially malignant disorders of the oral cavity. Oral Oncol 2011;47(9):920–921. DOI: 10.1016/j.oraloncology.2011.06.005.
  12. Sarode SC, Sarode GS, et al. Oral potentially malignant disorders: precising the definition. Oral Oncol 2012;9(48):759–760. DOI: 10.1016/j.oraloncology.2012.02.025.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.